Sand Hill Global Advisors, LLC Bristol Myers Squibb CO Transaction History

Sand Hill Global Advisors, LLC

$2.37 Billion
Q3 2024

A detailed history of Sand Hill Global Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sand Hill Global Advisors, LLC holds 5,934 shares of BMY stock, worth $348,800. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,934

Previous 5,934 -0.0%

Holding current value

$348,800

Previous $246,000 24.8%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $2,777 - $3,656	-69 Reduced 1.15%	5,934 $246,000
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $3,781 - $4,512	-78 Reduced 1.28%	6,003 $308,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $23,734 - $26,539	-410 Reduced 6.32%	6,081 $352,000
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $7,645 - $8,488	-120 Reduced 1.82%	6,491 $415,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $164,274 - $186,325	2,500 Added 60.81%	6,611 $458,000
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $63,960 - $75,738	-934 Reduced 18.51%	4,111 $295,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $88 - $52,558	684 Added 15.68%	5,045 $359,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $16,920 - $18,635	233 Added 5.64%	4,361 $336,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $375 - $437	-7 Reduced 0.17%	4,128 $257,000
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $15,384 - $18,020	260 Added 6.71%	4,135 $245,000
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $14,548 - $15,843	235 Added 6.46%	3,875 $259,000
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $8,188 - $9,210	138 Added 3.94%	3,640 $230,000
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $33,777 - $38,276	-585 Reduced 14.31%	3,502 $217,000
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $12,519 - $13,873	218 Added 5.63%	4,087 $246,000
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $1,206 - $1,409	-22 Reduced 0.57%	3,869 $227,000
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $35,217 - $51,179	-759 Reduced 16.32%	3,891 $217,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $228,826 - $298,483	4,650 New	4,650 $298,000
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $250,362 - $276,846	-5,611 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $253,168 - $301,871	5,611 New	5,611 $268,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $199,135 - $258,231	-4,084 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$50.53 - $62.98 $206,364 - $257,210	4,084 New	4,084 $226,000
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $207,922 - $239,360	-3,470 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $29,850 - $32,544	-498 Reduced 12.55%	3,470 $213,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $219,152 - $252,920	3,968	3,968 $253,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sand Hill Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sand Hill Global Advisors, LLC with notifications on news.

Account

Sand Hill Global Advisors, LLC Bristol Myers Squibb CO Transaction History